NPCE Q3 2024 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+28.2% YoY

Gross Profit

$15M73.2% margin

Operating Income

-$4M-20.1% margin

Net Income

-$5M-25.9% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$96M

Total Liabilities

$86M

Stockholders' Equity

$10M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$16M	+28.2%
Gross Profit	$15M	$12M	+26.1%
Operating Income	-$4M	-$6M	+28.7%
Net Income	-$5M	-$7M	+24.9%